Key facts
- Notable investors include Innoangel Fund, K2VC, Hunan Lushan Technology Investment, Tsinghua Capital, Lingyi Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Kingcera
- ·The full record, as it builds
Funding rounds
No funding rounds for Kingcera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kingcera
Researcher and developer of biomaterial products intended for dental materials industry. The company applies innovative composite materials technology to research and development of dental prosthetics, implants, bone and joint, 3D printing biomaterials, etc., enabling enterprises in the medical device industry with innovative and upgraded biomaterials.
- Sector
- Healthcare
- HQ
- Zhuzhou, China
- Founded
- 2022
- Employees
- 40
- Website
- king-cera.com/
- Ownership
- Privately Held (backing)
Kingcera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kingcera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kingcera in its N-PORT filings yet. We sweep new filings monthly.